These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33095651)

  • 41. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart.
    Haass M; Cheng B; Richardt G; Lang RE; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):71-8. PubMed ID: 2566928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum.
    Dey M; Michalkiewicz M; Huffman L; Hedge GA
    Peptides; 1993; 14(6):1179-86. PubMed ID: 8134299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
    Dietrich P; Moleda L; Kees F; Müller M; Straub RH; Hellerbrand C; Wiest R
    J Hepatol; 2013 Feb; 58(2):254-61. PubMed ID: 23041305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.
    Hall GT; Gardner TD; Potter EK
    Circ Res; 1990 Jul; 67(1):193-8. PubMed ID: 2364490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia.
    Kaijser L; Pernow J; Berglund B; Grubbström J; Lundberg JM
    J Appl Physiol (1985); 1994 Mar; 76(3):1346-9. PubMed ID: 8005881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay.
    Straub RH; Schaller T; Miller LE; von Hörsten S; Jessop DS; Falk W; Schölmerich J
    J Neurochem; 2000 Dec; 75(6):2464-71. PubMed ID: 11080198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of surgical sympathectomy on rat heart concentrations of neuropeptide Y-immunoreactivity and noradrenaline.
    Maccarrone C; Jarrott B
    J Auton Nerv Syst; 1987 Dec; 21(2-3):101-7. PubMed ID: 3450689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
    Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP
    J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neuropeptides, VIP and NPY, that are present in the thyroid nerves are not released into the thyroid vein.
    Michalkiewicz M; Dey M; Huffman LJ; Hedge GA
    Thyroid; 1998 Nov; 8(11):1071-7. PubMed ID: 9848726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: modulation by single components of ischaemia.
    Krüger C; Haunstetter A; Gerber S; Serf C; Kaufmann A; Kübler W; Haass M
    J Mol Cell Cardiol; 1995 Aug; 27(8):1491-506. PubMed ID: 8523413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropeptide Y is a cotransmitter with norepinephrine in guinea pig inferior mesenteric vein.
    Smyth L; Bobalova J; Ward SM; Mutafova-Yambolieva VN
    Peptides; 2000 Jun; 21(6):835-43. PubMed ID: 10959006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasoactive intestinal peptide and neuropeptide Y coexist in non-noradrenergic sympathetic neurons to guinea pig trachea.
    Bowden JJ; Gibbins IL
    J Auton Nerv Syst; 1992 Apr; 38(1):1-19. PubMed ID: 1588001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
    Lacroix JS; Ulman LG; Potter EK
    Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An animal and clinical study on the change of neuropeptide Y release evoked by electrical stimulation and myocardial ischemia.
    Cheng B; He Y; Xiang J; Guo L; Han Q
    Chin Med J (Engl); 1999 May; 112(5):410-3. PubMed ID: 11593509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological separation of cardio-accelerator and vagal inhibitory capacities of sympathetic nerves.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Apr; 43(1):7-16. PubMed ID: 8315212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.